Spots Global Cancer Trial Database for Laser Ablation After Stereotactic Radiosurgery
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Laser Ablation After Stereotactic Radiosurgery
Official Title: Laser Ablation After Stereotactic Radiosurgery
Study ID: NCT01651078
Interventions
Study Description
Brief Summary: The need for new technologies and devices in the field of neurosurgery is well established. In April 2013, FDA cleared NeuroBlate™ System, minimally invasive robotic laser thermotherapy tool. It employs a pulsed surgical laser to deliver targeted energy to abnormal brain tissue caused by tumors and lesions. This post-marketing, multi-center study will include patients with metastatic tumors who failed stereotactic radiosurgery and are already scheduled for NeuroBlate procedure. The study will collect clinical outcome, Quality of Life (QoL) and, where feasible, healthcare utilization data for publication.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Yale School of Medicine, New Haven, Connecticut, United States
Kansas University Medical Center, Kansas City, Kansas, United States
Washington University in St Louis, Saint Louis, Missouri, United States
Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina, United States
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States
Cleveland Clinic, Cleveland, Ohio, United States
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Contact Details
Name: Veronica Chiang, MD
Affiliation: Yale School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
